Scott J King, MD - Medicare Interventional Radiology in Mishawaka, IN

Scott J King, MD is a medicare enrolled "Radiology - Vascular & Interventional Radiology" physician in Mishawaka, Indiana. He went to University Of Cincinnati College Of Medicine and graduated in 2006 and has 18 years of diverse experience with area of expertise as Interventional Radiology. He is a member of the group practice Intercoastal Medical Group Inc, Mori Bean And Brooks Inc, Tower Imaging Llc and his current practice location is 611 E Douglas Rd Ste 200, Mishawaka, Indiana. You can reach out to his office (for appointments etc.) via phone at (574) 272-5347.

Scott J King is licensed to practice in Indiana (license number 01070924A) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1477765071.

Contact Information

Scott J King, MD
611 E Douglas Rd Ste 200,
Mishawaka, IN 46545-1465
(574) 272-5347
(574) 272-8617



Physician's Profile

Full NameScott J King
GenderMale
SpecialityInterventional Radiology
Experience18 Years
Location611 E Douglas Rd Ste 200, Mishawaka, Indiana
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Scott J King attended and graduated from University Of Cincinnati College Of Medicine in 2006
  NPI Data:
  • NPI Number: 1477765071
  • Provider Enumeration Date: 05/04/2007
  • Last Update Date: 09/15/2020
  Medicare PECOS Information:
  • PECOS PAC ID: 5991969578
  • Enrollment ID: I20210428003029

Medical Identifiers

Medical identifiers for Scott J King such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1477765071NPI-NPPES
201072620MedicaidIN

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
2085R0202XRadiology - Diagnostic Radiology 01070924A (Indiana)Secondary
2085R0204XRadiology - Vascular & Interventional Radiology 01070924A (Indiana)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Sarasota Memorial HospitalSarasota, FLHospital
Sacred Heart HospitalPensacola, FLHospital
Doctors Hospital Of SarasotaSarasota, FLHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Intercoastal Medical Group Inc6305730912165
Mori Bean And Brooks Inc8820077878633
Tower Imaging Llc2860470077107

News Archive

Plant scientists reveal genetic mechanism that enables viral organisms to cause diseases

CSIRO plant scientists have shed light on a problem that has puzzled researchers since the first virus was discovered in 1892 - how exactly do they cause disease? In a major breakthrough that helps us better understand how viruses cause diseases in plants - and potentially in animals and humans - Dr Ming-Bo Wang and Neil Smith of CSIRO Plant Industry have revealed a genetic mechanism that enables viral organisms to infect hosts and cause diseases.

Cornerstone Pharmaceuticals includes Mary Crowley Research Centers in CPI-613 clinical trials

Cornerstone Pharmaceuticals, Inc. today announced the addition of Mary Crowley Cancer Research Centers to its roster of sites for its ongoing Phase I/II clinical trials of its first-in-class anti-cancer agent, CPI-613. Cornerstone is a leader in the discovery and development of cancer therapies that capitalize upon and disrupt the unique metabolic processes of cancer cells.

Lawmakers discuss plans for SCHIP reauthorization

Sen. Edward Kennedy (D-Mass.) on Monday at a forum co-sponsored by the Alliance for Health Reform and the Robert Wood Johnson Foundation said that Congress likely will have the ability to authorize the $50 billion over five years needed to enroll all children eligible for SCHIP but "hedged on whether it would do so this year or over the next several years," CQ HealthBeat reports.

BioNJ creates special diagnostics committee to focus on personalized medicine

The strength of New Jersey's life sciences community and its unique ability to contribute to one of medicine's fastest growing areas—personalized medicine—has prompted BioNJ, the voice of the biotechnology industry in New Jersey, to create a special Diagnostics Committee.

Read more Medical News

› Verified 1 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Scott J King allows following entities to bill medicare on his behalf.
Entity NameNorth Brevard Medical Support Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1609834886
PECOS PAC ID: 7618870296
Enrollment ID: O20040130000385

News Archive

Plant scientists reveal genetic mechanism that enables viral organisms to cause diseases

CSIRO plant scientists have shed light on a problem that has puzzled researchers since the first virus was discovered in 1892 - how exactly do they cause disease? In a major breakthrough that helps us better understand how viruses cause diseases in plants - and potentially in animals and humans - Dr Ming-Bo Wang and Neil Smith of CSIRO Plant Industry have revealed a genetic mechanism that enables viral organisms to infect hosts and cause diseases.

Cornerstone Pharmaceuticals includes Mary Crowley Research Centers in CPI-613 clinical trials

Cornerstone Pharmaceuticals, Inc. today announced the addition of Mary Crowley Cancer Research Centers to its roster of sites for its ongoing Phase I/II clinical trials of its first-in-class anti-cancer agent, CPI-613. Cornerstone is a leader in the discovery and development of cancer therapies that capitalize upon and disrupt the unique metabolic processes of cancer cells.

Lawmakers discuss plans for SCHIP reauthorization

Sen. Edward Kennedy (D-Mass.) on Monday at a forum co-sponsored by the Alliance for Health Reform and the Robert Wood Johnson Foundation said that Congress likely will have the ability to authorize the $50 billion over five years needed to enroll all children eligible for SCHIP but "hedged on whether it would do so this year or over the next several years," CQ HealthBeat reports.

BioNJ creates special diagnostics committee to focus on personalized medicine

The strength of New Jersey's life sciences community and its unique ability to contribute to one of medicine's fastest growing areas—personalized medicine—has prompted BioNJ, the voice of the biotechnology industry in New Jersey, to create a special Diagnostics Committee.

Read more Medical News

› Verified 1 days ago

Entity NameIntercoastal Medical Group Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1578537767
PECOS PAC ID: 6305730912
Enrollment ID: O20040212000600

News Archive

Plant scientists reveal genetic mechanism that enables viral organisms to cause diseases

CSIRO plant scientists have shed light on a problem that has puzzled researchers since the first virus was discovered in 1892 - how exactly do they cause disease? In a major breakthrough that helps us better understand how viruses cause diseases in plants - and potentially in animals and humans - Dr Ming-Bo Wang and Neil Smith of CSIRO Plant Industry have revealed a genetic mechanism that enables viral organisms to infect hosts and cause diseases.

Cornerstone Pharmaceuticals includes Mary Crowley Research Centers in CPI-613 clinical trials

Cornerstone Pharmaceuticals, Inc. today announced the addition of Mary Crowley Cancer Research Centers to its roster of sites for its ongoing Phase I/II clinical trials of its first-in-class anti-cancer agent, CPI-613. Cornerstone is a leader in the discovery and development of cancer therapies that capitalize upon and disrupt the unique metabolic processes of cancer cells.

Lawmakers discuss plans for SCHIP reauthorization

Sen. Edward Kennedy (D-Mass.) on Monday at a forum co-sponsored by the Alliance for Health Reform and the Robert Wood Johnson Foundation said that Congress likely will have the ability to authorize the $50 billion over five years needed to enroll all children eligible for SCHIP but "hedged on whether it would do so this year or over the next several years," CQ HealthBeat reports.

BioNJ creates special diagnostics committee to focus on personalized medicine

The strength of New Jersey's life sciences community and its unique ability to contribute to one of medicine's fastest growing areas—personalized medicine—has prompted BioNJ, the voice of the biotechnology industry in New Jersey, to create a special Diagnostics Committee.

Read more Medical News

› Verified 1 days ago

Entity NameTower Imaging Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1467654244
PECOS PAC ID: 2860470077
Enrollment ID: O20040713000446

News Archive

Plant scientists reveal genetic mechanism that enables viral organisms to cause diseases

CSIRO plant scientists have shed light on a problem that has puzzled researchers since the first virus was discovered in 1892 - how exactly do they cause disease? In a major breakthrough that helps us better understand how viruses cause diseases in plants - and potentially in animals and humans - Dr Ming-Bo Wang and Neil Smith of CSIRO Plant Industry have revealed a genetic mechanism that enables viral organisms to infect hosts and cause diseases.

Cornerstone Pharmaceuticals includes Mary Crowley Research Centers in CPI-613 clinical trials

Cornerstone Pharmaceuticals, Inc. today announced the addition of Mary Crowley Cancer Research Centers to its roster of sites for its ongoing Phase I/II clinical trials of its first-in-class anti-cancer agent, CPI-613. Cornerstone is a leader in the discovery and development of cancer therapies that capitalize upon and disrupt the unique metabolic processes of cancer cells.

Lawmakers discuss plans for SCHIP reauthorization

Sen. Edward Kennedy (D-Mass.) on Monday at a forum co-sponsored by the Alliance for Health Reform and the Robert Wood Johnson Foundation said that Congress likely will have the ability to authorize the $50 billion over five years needed to enroll all children eligible for SCHIP but "hedged on whether it would do so this year or over the next several years," CQ HealthBeat reports.

BioNJ creates special diagnostics committee to focus on personalized medicine

The strength of New Jersey's life sciences community and its unique ability to contribute to one of medicine's fastest growing areas—personalized medicine—has prompted BioNJ, the voice of the biotechnology industry in New Jersey, to create a special Diagnostics Committee.

Read more Medical News

› Verified 1 days ago

Entity NameMori Bean And Brooks Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1093782070
PECOS PAC ID: 8820077878
Enrollment ID: O20040714001317

News Archive

Plant scientists reveal genetic mechanism that enables viral organisms to cause diseases

CSIRO plant scientists have shed light on a problem that has puzzled researchers since the first virus was discovered in 1892 - how exactly do they cause disease? In a major breakthrough that helps us better understand how viruses cause diseases in plants - and potentially in animals and humans - Dr Ming-Bo Wang and Neil Smith of CSIRO Plant Industry have revealed a genetic mechanism that enables viral organisms to infect hosts and cause diseases.

Cornerstone Pharmaceuticals includes Mary Crowley Research Centers in CPI-613 clinical trials

Cornerstone Pharmaceuticals, Inc. today announced the addition of Mary Crowley Cancer Research Centers to its roster of sites for its ongoing Phase I/II clinical trials of its first-in-class anti-cancer agent, CPI-613. Cornerstone is a leader in the discovery and development of cancer therapies that capitalize upon and disrupt the unique metabolic processes of cancer cells.

Lawmakers discuss plans for SCHIP reauthorization

Sen. Edward Kennedy (D-Mass.) on Monday at a forum co-sponsored by the Alliance for Health Reform and the Robert Wood Johnson Foundation said that Congress likely will have the ability to authorize the $50 billion over five years needed to enroll all children eligible for SCHIP but "hedged on whether it would do so this year or over the next several years," CQ HealthBeat reports.

BioNJ creates special diagnostics committee to focus on personalized medicine

The strength of New Jersey's life sciences community and its unique ability to contribute to one of medicine's fastest growing areas—personalized medicine—has prompted BioNJ, the voice of the biotechnology industry in New Jersey, to create a special Diagnostics Committee.

Read more Medical News

› Verified 1 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Scott J King is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Scott J King, MD
121 S Saint Louis Blvd,
South Bend, IN 46617-2924

Ph: (574) 233-3123
Scott J King, MD
611 E Douglas Rd Ste 200,
Mishawaka, IN 46545-1465

Ph: (574) 272-5347

News Archive

Plant scientists reveal genetic mechanism that enables viral organisms to cause diseases

CSIRO plant scientists have shed light on a problem that has puzzled researchers since the first virus was discovered in 1892 - how exactly do they cause disease? In a major breakthrough that helps us better understand how viruses cause diseases in plants - and potentially in animals and humans - Dr Ming-Bo Wang and Neil Smith of CSIRO Plant Industry have revealed a genetic mechanism that enables viral organisms to infect hosts and cause diseases.

Cornerstone Pharmaceuticals includes Mary Crowley Research Centers in CPI-613 clinical trials

Cornerstone Pharmaceuticals, Inc. today announced the addition of Mary Crowley Cancer Research Centers to its roster of sites for its ongoing Phase I/II clinical trials of its first-in-class anti-cancer agent, CPI-613. Cornerstone is a leader in the discovery and development of cancer therapies that capitalize upon and disrupt the unique metabolic processes of cancer cells.

Lawmakers discuss plans for SCHIP reauthorization

Sen. Edward Kennedy (D-Mass.) on Monday at a forum co-sponsored by the Alliance for Health Reform and the Robert Wood Johnson Foundation said that Congress likely will have the ability to authorize the $50 billion over five years needed to enroll all children eligible for SCHIP but "hedged on whether it would do so this year or over the next several years," CQ HealthBeat reports.

BioNJ creates special diagnostics committee to focus on personalized medicine

The strength of New Jersey's life sciences community and its unique ability to contribute to one of medicine's fastest growing areas—personalized medicine—has prompted BioNJ, the voice of the biotechnology industry in New Jersey, to create a special Diagnostics Committee.

Read more News

› Verified 1 days ago


Radiology Doctors in Mishawaka, IN

Samir B Patel, MD
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 620 W Edison Rd, Suite 110, Mishawaka, IN 46545
Phone: 574-258-1100    Fax: 574-258-1101
James C Field, MD
Radiology
Medicare: Not Enrolled in Medicare
Practice Location: 620 W Edison Rd, Suite 110, Mishawaka, IN 46545
Phone: 547-258-1100    Fax: 574-258-1101
Mark J Ormson, MD
Radiology
Medicare: Not Enrolled in Medicare
Practice Location: 620 W Edison Rd, Suite 110, Mishawaka, IN 46545
Phone: 574-258-1100    Fax: 574-258-1101
John C Hill, DO
Radiology
Medicare: Not Enrolled in Medicare
Practice Location: 620 W Edison Rd, Suite 110, Mishawaka, IN 46545
Phone: 574-258-1100    Fax: 574-258-1101
Mary C Dynes, MD
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 620 W Edison Rd, Suite 110, Mishawaka, IN 46545
Phone: 574-258-1100    Fax: 574-258-1101
Francoise M Dion, MD
Radiology
Medicare: Not Enrolled in Medicare
Practice Location: 620 W Edison Rd, Suite 110, Mishawaka, IN 46545
Phone: 574-258-1100    Fax: 574-258-1101
Christine Marsch O'malley, MD
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 620 W Edison Rd, Suite 110, Mishawaka, IN 46545
Phone: 574-258-1100    Fax: 574-258-1101

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.